MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,070,784 | +12.0% | 84,660 | -2.4% | 0.01% | +14.3% |
| Q1 2024 | $1,848,679 | -2.5% | 86,711 | -12.5% | 0.01% | 0.0% |
| Q4 2023 | $1,897,004 | -58.6% | 99,112 | -33.9% | 0.01% | -78.1% |
| Q2 2021 | $4,582,000 | -18.6% | 149,831 | -18.9% | 0.03% | -22.0% |
| Q1 2021 | $5,628,000 | +98.1% | 184,827 | +28.6% | 0.04% | +70.8% |
| Q4 2020 | $2,841,000 | -16.1% | 143,679 | -44.7% | 0.02% | -14.3% |
| Q3 2020 | $3,387,000 | -41.1% | 259,739 | -48.8% | 0.03% | -57.6% |
| Q2 2020 | $5,748,000 | +1230.6% | 506,870 | +1577.4% | 0.07% | +450.0% |
| Q1 2020 | $432,000 | -38.1% | 30,217 | +25.8% | 0.01% | -62.5% |
| Q4 2018 | $698,000 | -82.8% | 24,023 | -72.8% | 0.03% | -63.6% |
| Q3 2018 | $4,058,000 | +23.3% | 88,221 | +0.1% | 0.09% | 0.0% |
| Q2 2018 | $3,292,000 | +161.1% | 88,090 | +140.0% | 0.09% | +225.9% |
| Q4 2017 | $1,261,000 | – | 36,710 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |